Exploring information exchange opportunities between Industry and - - PowerPoint PPT Presentation

Exploring information exchange

• pportunities between Industry

and the TGA

ARCS PV Teleconference Dr Richard Hill and Warren Arndt Pharmacovigilance and Special Access Branch PMSBSystems@tga.gov.au 17th November 2015

Contents

• TGA’s Business Improvement Programme
• Background
• Adverse Event Management project
• What’s next?
• How to register
• Questions and Answers

Exploring information exchange opportunities between Sponsors and the TGA 1

TGA’s Business Improvement Programme

The TGA is currently undertaking a programme of reform to ensure that it remains adaptable to both industry and community expectations. A Business Improvement Programme (BIP) has been established within the TGA to improve the efficiency and effectiveness of the services provided by the TGA. The programme includes significant Information and Communications Technology (ICT) improvements that will support the needs of both the TGA and the stakeholder community, now and into the future. The TGA has started an Adverse Event Management (AEM) project under BIP to improve the current business systems and processes.

2

Background

• The TGA has separate systems for the collection and processing of adverse

event reports.

• The Adverse Drug Reaction System (ADRS) is used for medicines and

vaccines.

• The Incident Reporting and Investigation Scheme (IRIS) system is used for

medical devices.

3

Adverse Drug Reaction System

• ADR data collection began 1964
• The ADRS system uses:

– Lotus Notes interface for data entry – Oracle data repository

• There are over 350,000 individual reports in the database.
• These reports have been received from sponsors, health professionals, state

and territory government and consumers.

4

Volume of medicine and vaccine reports

Origin of adverse event reports received by the TGA (2010-2014)

1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 2010 2011 2012 2013 2014

Number of reprots Year General Practitioners Hospitals (including hospital pharmacists) Community pharmacists Consumers Sponsors State and Territory Health Departments Other

5

How reports are received in ADRS

• Email*, fax and mail
• Telephone i.e. via Adverse Medicine Event Line (NPS) – consumers
• Online forms on TGA website

– Unregistered users – Registered users

• ADRS Web Service

* Includes emails with E2B structured xml files

6

Adverse Event Management Project

Scope The scope of the AEM project includes all therapeutic products (medicines, vaccines, biologicals and medical devices) for the following activities:

• 1. The collection and processing of adverse event and problem reports
• 2. The analysis of information to detect safety signals
• 3. The review of safety signals identified from adverse event data and other

information sources

• 4. Associated reporting requirements to support the above activities

7

Adverse Event Management Project

Key Business Objectives

• Improve the data quality, exchange and reporting of adverse event information
• Streamline the processing of adverse event information
• Reduce the regulatory burden for mandatory reporters of adverse event

information

• Improve the signal detection and management capabilities

8

Adverse Event Management Project

Expected benefits

• Improved user experience for reporters of adverse event information
• Efficiency gains in processing adverse event reports to handle the continual

increases in volume

• To ensure all reports are collected and stored in a structured format that aligns with

international standards to support data exchange, intelligence and analytics

• Improved and more efficient detection and processing of safety signals

9

Proposed reporting formats

• System to system transactions
• Online forms on TGA website

– Unregistered users – Registered users

• Email, fax and mail
• Telephone

10

System to System - E2B/HL7

• ICH E2BM working group developed a guideline to facilitate the

standardisation of the data elements for the transmission of individual case safety reports (ICSRs).

• ICH then developed a standard (E2B R2) for the electronic transmission of

ICSRs which used standard generalised markup language (SGML) and a document type definition (DTD) describing the data elements and their relationships.

• E2B R3 is the latest standard based upon an HL7 ICSR model that is capable
• f supporting message exchange for a broad range of products.

11

E2B/HL7 cont.

• E2B R3 uses an ‘ICH-subset’ of the data elements within the ISO/HL7 27953-

2:2011 standard

• The ISO/HL7 27953-2:2011 standard is based upon ISO N545 and HL7 ICSR

Release 1 and 2

• HL7 ICSR standard supports the exchange of data and other safety reporting

requirements such as adverse events and product problems associated with the use of therapeutic products

• ISO/HL7 27953-2:2011 uses HL7 V3 messaging

12

What next?

The TGA would like to understand the current and planned capabilities of your adverse event management systems in terms of exchanging adverse event

• information. For example, are you exchanging adverse event information in the

E2B R3 format with overseas regulators? This information will assist us in developing reporting formats under AEMS which meet our stakeholder needs. We would also be interested in working with you to identify other potential benefits e.g. self service capability which you believe could add the most value to your

• rganisation.

13

How to register

• You can register your interest in participating in the AEMS project by emailing

your details to PMSBSystems@tga.gov.au.

• The provided details should include:

– Your name – Organisation – Email address – Phone number Thank you in advance for your time and contribution, we highly value your support during this process.

14

Questions and Answers

15